The RAS/MAPK Axis Gets Stressed Out

Slides:



Advertisements
Similar presentations
Extracellular Environment. Extracellular Environment.
Advertisements

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Lung Cancer Tumour Markers
Cell Signaling Pathways – A Case Study Approach
Alexander Loewer, Galit Lahav  Cell 
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Sustaining Proliferative Signaling and Evading Growth Suppressors
Connecting COX-2 and Wnt in cancer
MAPK pathway inhibitors.
Miriam Marqués, Francisco X. Real  European Urology 
Activation of mitogen-activated protein kinases during preparation of vein grafts and modulation by a synthetic inhibitor  Costas Bizekis, MD, Giuseppe.
Nomeda Girnius, Roger J. Davis  Cancer Cell 
All roads lead to FoxO Cell Metabolism
Cold Signal Shuttles from Membrane to Nucleus
The Akt-mTOR tango and its relevance to cancer
RAS unplugged: Negative feedback and oncogene-induced senescence
Yorkie and Scalloped: Partners in Growth Activation
Electromagnetic fields stress living cells
Keratins and the Keratinocyte Activation Cycle
Stressed-Out HSCs Turn Up p38α and Purine to Proliferate
Deconstructing ERK Signaling in Tumorigenesis
Methed-Up FOXOs Can't In-Akt-ivate
A Radical Role for p38 MAPK in Tumor Initiation
A genome-based strategy uncovers frequent BRAF mutations in melanoma
Toru Furukawa  Clinical Gastroenterology and Hepatology 
Foxo1 and Foxo3 help Foxp3 Immunity
Volume 46, Issue 5, Pages (June 2012)
Raf-1 and Squamous Cell Carcinoma: Rok-ing the Boat
Vascular Endothelial Growth Factor (VEGF) Pathway
William G. Kaelin, Peter J. Ratcliffe  Molecular Cell 
Connecting Mitochondria and Innate Immunity
Selective Insulin and Leptin Resistance in Metabolic Disorders
Stress Flips a Chromatin Switch to Wake Up Latent Virus
The RAF Inhibitor Paradox Revisited
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Signal Transduction: RABGEF1 Fingers RAS for Ubiquitination
Volume 73, Issue 1, Pages 5-7 (January 2008)
A New FOXO Pathway Required for Leukemogenesis
RAS and PD-L1: A Masters’ Liaison in Cancer Immune Evasion
Epigenetic Mechanisms in Cognition
p38δ and PKD1: Kinase Switches for Insulin Secretion
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
SRC and STAT Pathways Journal of Thoracic Oncology
Volume 49, Issue 1, Pages 1-3 (January 2013)
Conspiracy Theory Cell
Volume 19, Issue 5, Pages (September 2005)
Volume 56, Pages S70-S75 (July 1999)
Insider Influence on ErbB Activity
Platelet-derived growth factor (PDGF) signalling pathway.
Intercellular Networks Underlying Developmental Decisions
Jinhua Tang, Na Liu, Shougang Zhuang  Kidney International 
Apoptosis: Current Biology
Molecular Characterization of Acquired Resistance to the BRAF Inhibitor Dabrafenib in a Patient with BRAF-Mutant Non–Small-Cell Lung Cancer  Charles M.
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
The mitogen-activated protein kinase (MAPK) pathway showing mutations identified in pulmonary Langerhans cell histiocytosis (PLCH). The mitogen-activated.
Mutant BRAF Melanomas—Dependence and Resistance
Signaling by Ras/Raf/ERK in the regulation of β-cell proliferation.
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Guilty as charged Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
Christina L. Rosenberger, Jie Chen  Molecular Cell 
Volume 25, Issue 2, Pages (January 2007)
TFII-IΔ and TFII-Iβ: Unequal Brothers Fostering Cellular Proliferation
c-Raf in KRas Mutant Cancers: A Moving Target
Mind the IQGAP Cancer Cell
The Regulatory T Cell Transcriptosome: E Pluribus Unum
AMPK and p53 help cells through lean times
Regulation of signaling by wild-type and oncogenic Ras.
Turning Reciprocal Feedback Regulation into Combination Therapy
Presentation transcript:

The RAS/MAPK Axis Gets Stressed Out Scott A. Foster, Shiva Malek  Molecular Cell  Volume 64, Issue 5, Pages 854-855 (December 2016) DOI: 10.1016/j.molcel.2016.11.024 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Mechanisms of MAPK Pathway Feedback Inhibition (A) Upon ligand (GF) activation, receptor tyrosine kinases (RTK) undergo autophosphorylation leading to the SOS-dependent conversion of RAS-GDP to RAS-GTP. Active RAS (RAS-GTP) promotes the dimerization and activation or RAF and the subsequent activation of the signaling cascade through MEK and ERK. Upon activation, ERK can translocate into the nucleus, turning on the transcription of pro-growth genes. In addition to its pro-growth role, active ERK also suppresses upstream pathway signaling (ERK-dependent negative feedback) by phosphorylating many components including RAF and SOS. (B) Rigosterib and other mitotic stress inducers such as Taxol induce the increase in reactive oxygen species (ROS) leading to the activation of JNK signaling. Active JNK can phosphorylate RAF and SOS, resulting in stress-induced suppression of RAS-MAPK signaling. Molecular Cell 2016 64, 854-855DOI: (10.1016/j.molcel.2016.11.024) Copyright © 2016 Elsevier Inc. Terms and Conditions